University of Connecticut Studies Drug-Carrying Nanoparticles - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

University of Connecticut Studies Drug-Carrying Nanoparticles

ePT--the Electronic Newsletter of Pharmaceutical Technology

Anson Ma, an assistant professor of chemical engineering at the University of Connecticut (UConn) has received a two-year National Science Foundation Early Concept Grant for Exploratory Research (EAGER) award to test the use of nanoparticles for drug delivery and to understand how nanoparticles flow in the bloodstream.

Nanoparticles are being considered to improve the delivery of cancer-fighting drugs to tumors while reducing the toxic side effects to normal tissues. “But blood is a very complicated fluid, and we don’t precisely know how the particles travel,” said Ma in a recent University press release.  The research team will build novel microfluidic devices that simulate the bloodstream and study the flow dynamics of nanoparticles within these simulated blood flows. The research will also consider the roles of blood constituents and of particle shape and size in delivering drugs to the tumor site and will investigate how certain factors like particle shape and surface chemistry influence the hydrodynamics of the nanoparticles.

“This project will be the first step in understanding the problem from an engineering perspective,” said Ma in the release. Ma and his student project team are collaborating with professors Leslie Shor from the Chemical Engineering department, Xiuling Lu from Pharmaceutical Sciences, and Suzy Torti from the UConn Health Center.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here